Skip to main content
. 2016 Nov 22;7(52):86730–86739. doi: 10.18632/oncotarget.13502

Figure 3. Kaplan-Meier curves showing (A) overall survival and; (B) disease-specific survival of p16-positive and p16-negative patients with oropharyngeal SCC.

Figure 3

Black line = p16-positive, dashed line= p16-negative. The p16-positive OPSCC has a significantly better overall survival (p = 0.022), but not disease-specific survival (p = 0.46).